261 related articles for article (PubMed ID: 32195672)
1. Prolonged progression-free survival and overall survival are associated with diabetes mellitus but inversely associated with levels of blood glucose in patients with lung cancer.
Wang NF; Tang HM; Liu FL; Hong QY
Chin Med J (Engl); 2020 Apr; 133(7):786-791. PubMed ID: 32195672
[TBL] [Abstract][Full Text] [Related]
2. Hypo- or conventionally fractionated radiotherapy combined with chemotherapy in patients with limited stage small cell lung cancer.
Zhang J; Fan M; Liu D; Zhao KL; Wu KL; Zhao WX; Zhu ZF; Fu XL
Radiat Oncol; 2017 Mar; 12(1):51. PubMed ID: 28283034
[TBL] [Abstract][Full Text] [Related]
3. Impact of diabetes mellitus on epithelial ovarian cancer survival.
Akhavan S; Ghahghaei-Nezamabadi A; Modaresgilani M; Mousavi AS; Sepidarkish M; Tehranian A; Rezayof E
BMC Cancer; 2018 Dec; 18(1):1246. PubMed ID: 30541490
[TBL] [Abstract][Full Text] [Related]
4. [A retrospective study of the impact of diabetes mellitus on survival in patients with lung cancer].
Han R; Yang G; Lyu Z; Gu W; Du J; Jin N; Zang L; Yang L; Guo Q; Ba J; Dou J; Mu Y
Zhonghua Nei Ke Za Zhi; 2015 Dec; 54(12):1028-31. PubMed ID: 26887369
[TBL] [Abstract][Full Text] [Related]
5. [The prognostic impact of diabetic mellitus and hyperglycemia during DLBCL treatment on patients with diffuse large B-cell lymphoma].
Hu Y; Xu YJ; Li MZ; Lan YX; Mao L; Ning QY; Xu W; Yang HL; Zhang YZ
Zhonghua Xue Ye Xue Za Zhi; 2021 Feb; 42(2):151-157. PubMed ID: 33858047
[No Abstract] [Full Text] [Related]
6. Diabetes mellitus is independently associated with adverse clinical outcome in soft tissue sarcoma patients.
Stelzl A; Aziz F; Riedl JM; Posch F; Smolle MA; Stojakovic T; Terbuch A; Pichler M; Bergovec M; Leithner A; Liegl-Atzwanger B; Stotz M; Gerger A; Sourij H; Szkandera J
Sci Rep; 2020 Jul; 10(1):12438. PubMed ID: 32709908
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic evaluation of nutritional indicators in patients with limited-stage small cell lung cancer].
Zhang JQ; Wang YY; Xu KP; Qi J; Wang X; Xu LM; Liu NN; Zhao LJ; Wang P
Zhonghua Zhong Liu Za Zhi; 2019 Dec; 41(12):937-942. PubMed ID: 31874552
[No Abstract] [Full Text] [Related]
8. Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity.
Luo Y; Feng B; Wei D; Han Y; Li M; Zhao J; Lin Y; Hou Z; Jiang Y
Sci Rep; 2020 Oct; 10(1):17674. PubMed ID: 33077839
[TBL] [Abstract][Full Text] [Related]
9. Increased C-reactive protein is associated with future development of diabetes mellitus in essential hypertensive patients.
Weng CM; Chou CH; Huang YY; Lin CC; Liu YW; Tsai WC
Heart Vessels; 2010 Sep; 25(5):386-91. PubMed ID: 20676960
[TBL] [Abstract][Full Text] [Related]
10. Influence of Hypertension on the Survival of Non-Small Cell Lung Cancer Patients with Type 2 Diabetes Mellitus.
Zeng X; Zeng D; Cheng J; Xu C; Sun C; Long H; Zhu B
Med Sci Monit; 2020 Apr; 26():e921676. PubMed ID: 32305990
[TBL] [Abstract][Full Text] [Related]
11. Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.
Bergamino M; Rullan AJ; Saigí M; Peiró I; Montanya E; Palmero R; Ruffinelli JC; Navarro A; Arnaiz MD; Brao I; Aso S; Padrones S; Cardenal F; Nadal E
BMC Cancer; 2019 Feb; 19(1):165. PubMed ID: 30791870
[TBL] [Abstract][Full Text] [Related]
12. Poor glycemic control might compromise the efficacy of chemotherapy in non-small cell lung cancer patients with diabetes mellitus.
Zeng X; Xu C; Cheng J; Sun C; Wang Z; Gong Z; Long H; Zhu B
Cancer Med; 2020 Feb; 9(3):902-911. PubMed ID: 31830375
[TBL] [Abstract][Full Text] [Related]
13. Is diabetes mellitus a negative prognostic factor for the treatment of advanced non-small-cell lung cancer?
Inal A; Kaplan MA; Kucukoner M; Urakcı Z; Kılınc F; Isıkdogan A
Rev Port Pneumol; 2014; 20(2):62-8. PubMed ID: 24210228
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance of Kinetics of Low-Density Lipoprotein Cholesterol and Its Prognostic Value in Limited Stage Small Cell Lung Cancer Patients.
Liu T; Zhou T; Luo F; Yang Y; Zhao S; Huang Y; Zhao H; Zhang L; Zhao Y
Cancer Control; 2021; 28():10732748211028257. PubMed ID: 34184581
[TBL] [Abstract][Full Text] [Related]
15. Validation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials.
Wang X; Wang X; Hodgson L; George SL; Sargent DJ; Foster NR; Ganti AK; Stinchcombe TE; Crawford J; Kratzke R; Adjei AA; Kindler HL; Vokes EE; Pang H
Oncologist; 2017 Feb; 22(2):189-198. PubMed ID: 28188257
[TBL] [Abstract][Full Text] [Related]
16. Diminishing prognostic role of preexisting diabetes mellitus for patients with diffuse large B-cell lymphoma in the rituximab era.
Lu HJ; Huang YC; Liu CY; Hung MH; Hu MH; Wu CY; Hong YC; Hsiao LT; Gau JP; Liu JH; Hsu HC; Chiou TJ; Tzeng CH; Yu YB
Ann Hematol; 2013 Nov; 92(11):1495-501. PubMed ID: 23712292
[TBL] [Abstract][Full Text] [Related]
17. Significance of preoperative prognostic nutrition index as prognostic predictors in patients with metastatic renal cell carcinoma with tyrosine kinase inhibitors as first-line target therapy.
Cai W; Zhong H; Kong W; Dong B; Chen Y; Zhou L; Xue W; Huang Y; Zhang J; Huang J
Int Urol Nephrol; 2017 Nov; 49(11):1955-1963. PubMed ID: 28889323
[TBL] [Abstract][Full Text] [Related]
18. The value of prognostic factors in Chinese patients with small cell lung cancer: A retrospective study of 999 patients.
Hong X; Xu Q; Yang Z; Wang M; Yang F; Gao Y; Zhou F; Wang L; Liu B; Chen G
Clin Respir J; 2018 Feb; 12(2):433-447. PubMed ID: 27460525
[TBL] [Abstract][Full Text] [Related]
19. Response criteria in solid tumors (PERCIST/RECIST) and SUV
Pierson C; Grinchak T; Sokolovic C; Holland B; Parent T; Bowling M; Arastu H; Walker P; Ju A
Radiat Oncol; 2018 Feb; 13(1):34. PubMed ID: 29486779
[TBL] [Abstract][Full Text] [Related]
20. The effect of post-progression survival on overall survival among patients with sensitive relapse of small cell lung cancer.
Miura Y; Imai H; Sakurai R; Kaira K; Sunaga N; Minato K; Saito R; Hisada T
Med Oncol; 2018 Mar; 35(4):45. PubMed ID: 29508094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
